Pregabalin Market: Global Industry Analysis and Forecast (2023-2029)

The Global Pregabalin market was valued at US$ 799.08 Mn. in 2022, and it is expected to reach US$ 1029.79 Mn. by 2029 with a CAGR of 3.69% during the forecast period. Pregabalin is an anticonvulsant and anxiolytic drug that is used to treat a variety of disorders, including epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalised anxiety disorder. It's a type of epilepsy treatment that's used to treat partial seizures. When given before surgery, it reduces pain but also causes sleepiness and visual disturbances of epilepsy patients live in low- and middle-income countries during the early stages of the disease.